Loading
Pancreatic cancer grows and spreads quickly, and delays between the scan that finds it, the specialist meeting, the biopsy, the bile duct stent and the first chemotherapy or operation are measured in weeks. The proposal is a dedicated fast-track pathway with a national standard for the interval from first imaging to first treatment, reported by the audit.
The National Pancreatic Cancer Audit reports intervals along the pathway (referral, diagnosis, multidisciplinary discussion, treatment) and the proportion treated; Pancreatic Cancer UK has campaigned for treatment within a set number of weeks of diagnosis. The clinical logic is that biliary obstruction must be relieved before chemotherapy (stent), tissue is needed before systemic treatment, and fitness declines while patients wait, so a pathway that runs staging CT, endoscopic ultrasound with biopsy and stenting, germline and tumour testing, dietetic and enzyme assessment and the specialist meeting in parallel within a fixed window is what shortens the interval. This is a placeholder for the specific UK figures and targets the UK and NHS page carries; the idea here is the measurement: adopt first imaging to first treatment as the audited interval, set a national standard, and test whether pathway redesign in a region shortens it without lowering the treatment rate.
Shares Run the ENDPAC score on every new diabetes diagnosis after 50 and scan the high scorers, CT (computed tomography), The hardest cancers are found late, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question and the tag pancreatic-evidence.
Shares Run the ENDPAC score on every new diabetes diagnosis after 50 and scan the high scorers, The hardest cancers are found late, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question, Pancreatic ductal adenocarcinoma and the tag pancreatic-evidence.
Shares Raise the share of UK patients who receive any active treatment, and publish it by trust, Fragmented care and guideline gaps, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question, Pancreatic ductal adenocarcinoma and the tag pancreatic-evidence.
Shares Raise the share of UK patients who receive any active treatment, and publish it by trust, Fragmented care and guideline gaps, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question, Pancreatic ductal adenocarcinoma and the tag pancreatic-evidence.
Shares Run the ENDPAC score on every new diabetes diagnosis after 50 and scan the high scorers, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question, Pancreatic ductal adenocarcinoma and the tag pancreatic-evidence.
Shares Run the ENDPAC score on every new diabetes diagnosis after 50 and scan the high scorers, The hardest cancers are found late, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question, Pancreatic ductal adenocarcinoma and the tag pancreatic-evidence.
Shares Fragmented care and guideline gaps, The hardest cancers are found late, Germline (hereditary) testing, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question and the tag pancreatic-evidence.
Shares CT (computed tomography), The hardest cancers are found late, Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question, Pancreatic ductal adenocarcinoma and the tag pancreatic-evidence.